Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Tina Rönn

Tina Rönn

Assistant researcher

Tina Rönn

Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy.

Author

  • Elisabet Agardh
  • Annika Lundstig
  • Alexander Perfilyev
  • Petr Volkov
  • Tove Freiburghaus
  • Eero Lindholm
  • Tina Rönn
  • Carl-David Agardh
  • Charlotte Ling

Summary, in English

Epigenetic variation has been linked to several human diseases. Proliferative diabetic retinopathy (PDR) is a major cause of vision loss in subjects with diabetes. However, studies examining the association between PDR and the genome-wide DNA methylation pattern are lacking. Our aim was to identify epigenetic modifications that associate with and predict PDR in subjects with type 1 diabetes (T1D).

Department/s

  • Ophthalmology (Malmö)
  • Diabetes and Celiac Unit
  • Diabetes - Epigenetics
  • Genomics, Diabetes and Endocrinology
  • Department of Clinical Sciences, Malmö
  • EXODIAB: Excellence in Diabetes Research in Sweden

Publishing year

2015

Language

English

Publication/Series

BMC Medicine

Volume

13

Issue

182

Document type

Journal article

Publisher

BioMed Central (BMC)

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Ophthalmology (Malmö)
  • Diabetes and Celiac Unit
  • Diabetes - Epigenetics
  • Genomics, Diabetes and Endocrinology

ISBN/ISSN/Other

  • ISSN: 1741-7015